Vaxxinova US Revenue and Competitors

Willmar, MN

Location

N/A

Total Funding

Veterinary

Industry

Employee Data

  • Vaxxinova US has 89 Employees.(i)
  • Vaxxinova US grew their employee count by 11% last year.

Vaxxinova US's People

NameTitleEmail/Phone
1
Head Research And DevelopmentReveal Email/Phone
2
Director Sales and MarketingReveal Email/Phone
3
Director ManufacturingReveal Email/Phone
4
Director Swine Business UnitReveal Email/Phone
5
Director FinanceReveal Email/Phone
6
Key Account ManagerReveal Email/Phone
7
Strategic Account ManagerReveal Email/Phone
8
Accounting ManagerReveal Email/Phone
9
Senior Territory Sales ManagerReveal Email/Phone
10
Maintenance and Engineering ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A10-9%N/AN/A
#2
$1.7M3124%N/AN/A
#3
$35M60N/AN/AN/A
#4
$3.5M343%N/AN/A
#5
$15M16523%N/AN/A
#6
$35M50211%N/AN/A
#7
$15M2969%N/AN/A
#8
N/A26-4%N/AN/A
#9
N/A343%N/AN/A
#10
$3.5M6313%N/AN/A
Add Company

What Is Vaxxinova US?

Vaxxinova US holds a USDA Establishment License No. 365 for the manufacturing of veterinary biologicals. Our mission is to perform discovery, research and development, and manufacturing of technologies to improve animal health and food safety. Vaxxinova US owns intellectual property rights to key technologies, including SRP® Technology, involving the production of highly efficacious and safe veterinary vaccines. We value key partnerships to assist in the marketing and distribution of USDA licensed products in the US and global animal health industries.

keywords:N/A

N/A

Total Funding

89

Number of Employees

N/A

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M95-7%N/A
#2
$29.2M11928%N/A
#3
$26.7M12410%N/A
#4
$21.5M1763%N/A
#5
N/A180-1%N/A